US7357809B2 - Chemically based vascular occlusion device deployment with gripping feature - Google Patents

Chemically based vascular occlusion device deployment with gripping feature Download PDF

Info

Publication number
US7357809B2
US7357809B2 US11/171,896 US17189605A US7357809B2 US 7357809 B2 US7357809 B2 US 7357809B2 US 17189605 A US17189605 A US 17189605A US 7357809 B2 US7357809 B2 US 7357809B2
Authority
US
United States
Prior art keywords
reactant
expandable
reaction chamber
occlusion device
gripper
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related, expires
Application number
US11/171,896
Other languages
English (en)
Other versions
US20070005098A1 (en
Inventor
Donald K. Jones
Vladimir Mitelberg
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Codman and Shurtleff Inc
Original Assignee
Cordis Neurovascular Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cordis Neurovascular Inc filed Critical Cordis Neurovascular Inc
Priority to US11/171,896 priority Critical patent/US7357809B2/en
Assigned to CORDIS DEVELOPMENT CORPORATION reassignment CORDIS DEVELOPMENT CORPORATION ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: JONES, DONALD K., MITELBERG, VLADIMIR
Assigned to CORDIS NEUROVASCULAR, INC. reassignment CORDIS NEUROVASCULAR, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: CORDIS DEVELOPMENT CORPORATION
Priority to EP06253235A priority patent/EP1738694B1/fr
Priority to DE602006001993T priority patent/DE602006001993D1/de
Priority to CA2551328A priority patent/CA2551328C/fr
Priority to JP2006180042A priority patent/JP5259058B2/ja
Publication of US20070005098A1 publication Critical patent/US20070005098A1/en
Publication of US7357809B2 publication Critical patent/US7357809B2/en
Application granted granted Critical
Assigned to CODMAN & SHURTLEFF, INC. reassignment CODMAN & SHURTLEFF, INC. MERGER (SEE DOCUMENT FOR DETAILS). Assignors: CORDIS NEUROVASCULAR, INC.
Expired - Fee Related legal-status Critical Current
Adjusted expiration legal-status Critical

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/12Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
    • A61B17/12022Occluding by internal devices, e.g. balloons or releasable wires
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/12Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
    • A61B17/12022Occluding by internal devices, e.g. balloons or releasable wires
    • A61B17/12131Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device
    • A61B17/1214Coils or wires
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/12Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
    • A61B17/12022Occluding by internal devices, e.g. balloons or releasable wires
    • A61B2017/1205Introduction devices
    • A61B2017/12054Details concerning the detachment of the occluding device from the introduction device
    • A61B2017/12081Details concerning the detachment of the occluding device from the introduction device detachable by inflation

Definitions

  • the present invention is related to deployment systems and methods for accurately and rapidly deploying vascular occlusion devices at a preselected location within the vascular system of a patient, and more particularly, deployment approaches that utilize a pusher having an expandable gripper which is opened by the action of an expandable chemical reaction chamber to facilitate rapid deployment of vascular occlusion devices.
  • catheter delivery systems for positioning and deploying therapeutic devices, such as dilation balloons, stents and embolic coils, in the vasculature of the human body has become a standard procedure for treating endovascular diseases. It has been found that such devices are particularly useful in treating areas where traditional operational procedures are impossible or pose a great risk to the patient, for example in the treatment of aneurysms in cranial blood vessels. Due to the delicate tissue surrounding cranial blood vessels, especially for example brain tissue, it is very difficult and often risky to perform surgical procedures to treat such a defect. Advancements in catheter deployment systems have provided an alternative treatment in such cases. Some of the advantages of catheter delivery systems are that they provide methods for treating blood vessels by an approach that has been found to reduce the risk of trauma to the surrounding tissue, and they also allow for treatment of blood vessels that in the past would have been considered inoperable.
  • these procedures involve inserting the distal end of a delivery catheter into the vasculature of a patient and guiding it through the vasculature to a predetermined delivery site.
  • a vascular occlusion device such as an embolic coil, is attached to the end of a delivery member which pushes the coil through the catheter and out of the distal end of the catheter into the delivery site.
  • Another coil deployment system employs a pusher member having an embolic coil attached to the pusher member by a connector fiber which is capable of being broken by heat, as disclosed in Lucas et al. U.S. Pat. No. 6,478,773.
  • the pusher member of this arrangement includes an electrical resistance heating coil through which the connector fiber is passed. Electrical current is supplied to the heating coil by a power source connected to the heating coil via wires extending through an internal lumen of the pusher. The power source is activated to increase the temperature of the heating coil which breaks the connector fiber.
  • One drawback is that connecting the resistance heating coil to the power source requires running multiple wires through the pusher member. Additionally, the electrical current traveling through the wires may create stray electromagnetic fields that interfere with other surgical and/or monitoring equipment.
  • a need remains for a rapid release vascular occlusion deployment system or method that does not rely on electrical equipment or a power supply, is simple to manufacture, flexible and easy to guide through the vasculature of the body, provides better control over the occlusion device, and reduces the possibility of interference with other surgical and/or monitoring equipment.
  • the present invention embodies deployment systems and methods for accurately and rapidly deploying a vascular occlusion device at a preselected site within the vasculature of a patient.
  • the deployment system may employ an elongated flexible delivery catheter for guiding a deployment unit to the preselected site.
  • the deployment unit includes a pusher which has a gripper located at a distal end portion of the pusher.
  • the gripper has an expandable gripping element, for example a plurality of gripping jaws, for releasably attaching a vascular occlusion device, such as an embolic coil, to the deployment system.
  • the pusher guides the vascular occlusion device through the delivery catheter to the preselected site.
  • the delivery system also includes a first dispensing unit for dispensing a first reactant into the reaction chamber and a second dispensing unit for dispensing a second reactant into the reaction chamber.
  • first and second reactants When the first and second reactants are dispensed into the chamber, they react to form a product that has a larger volume than the combined volumes of the first and second reactants prior to reacting.
  • the product pushes against the inner wall of the expandable reaction chamber which causes the reaction chamber to outwardly expand.
  • the reaction chamber As the reaction chamber expands, it pushes against the gripping element causing the gripping element to outwardly expand or open so that the gripping element releases the vascular occlusion device, thereby deploying the vascular occlusion device at the preselected location.
  • FIG. 1 is an enlarged, partially sectioned view of the vascular occlusion device deployment system of a preferred embodiment of the present invention
  • FIG. 2 is an enlarged partially sectioned view showing the deployment unit of FIG. 1 prior to deployment of the occlusion device;
  • FIG. 3 is an enlarged partially sectioned view of the deployment unit of FIG. 2 shown just after deployment of the vascular occlusion device;
  • FIG. 4 is an enlarged partially sectioned view of the deployment system of FIG. 1 positioned at a preselected location within the vasculature system of a patient;
  • FIG. 5 is an enlarged partially sectioned view of the deployment system of FIG. 1 positioned at a preselected location within the vasculature system of a patient with the vascular occlusion device extending out of the distal end of the delivery catheter;
  • FIG. 6 is an enlarged partially sectioned view of the deployment system of FIG. 1 shown just after the vascular occlusion device has been deployed at a preselected location within the vasculature system of a patient.
  • FIG. 1 generally illustrates a preferred embodiment of the vascular occlusion device deployment system of the present invention.
  • the deployment system generally designated at 10 , includes an elongated flexible guiding catheter 12 which is inserted into the vascular system of a patient and used to guide a deployment unit, generally designed 14 , to a preselected site in a manner generally known in the art.
  • the deployment system 14 includes an elongated flexible pusher or delivery tube 16 having a proximal end portion 18 and a distal end portion 20 .
  • a gripper 22 is located at the distal end portion 20 of the pusher 16 .
  • the gripper 22 includes an outwardly expandable gripping element 24 , which is generally illustrated as a plurality of jaws.
  • the gripping element 24 releasably engages a protruding portion or headpiece 26 of a vascular occlusion device 28 , such as an embolic coil.
  • a vascular occlusion device 28 such as an embolic coil
  • the gripper 22 may be comprised of polymer, such as FEP Teflon, PTFE Teflon, polyvinyl chloride, a polyolefin or a neoprene, or any other suitable polymer, and may be constructed as disclosed in Bennett et al. U.S. Pat. No. 5,609,608, hereby incorporated herein by reference.
  • the gripper 22 may be constructed of any suitable metal, or the gripper could comprise a microtube which has been slit.
  • a suitable microtube may be made of stainless steel or of a nickel-titanium alloy such as Nitinol, or other suitable material.
  • the gripper 22 is a separated unit which is attached to the pusher 16 in any suitable manner, for example by a silicone or cyanoacrylate adhesive.
  • the gripper 22 and pusher 16 could be a unitary structure.
  • the occlusion device 28 may be an embolic coil which may take various forms and configurations, and may also be filled with a fibrous material or may be coated with a beneficial substance, such as a biogel to promote clotting.
  • the occlusion device also may be any other occlusion device or approach known in the art such as hydrogels, foams, bioactive coils, braids, cables, and hybrid devices.
  • the reaction chamber 30 is positioned within the gripper 22 .
  • the reaction chamber 30 which for illustrative purposes is depicted as a microballoon, is preferably comprised of an elastic membrane 31 .
  • the elastic membrane may be constructed from materials that do not significantly degrade while in contact with the reactant materials or the product formed therefrom. Typically, these will be an elastic polymer, such as silicone, a polyamide, a nylon, or a polyolefin such as polyethylene.
  • the reaction chamber 30 includes a cavity 32 defined by the inner surface 33 of the membrane 31 .
  • the delivery unit 14 also includes a first dispensing unit 34 for dispensing a first reactant 36 into the cavity 32 of the reaction chamber 30 and a second dispensing unit 38 for dispensing a second reactant 40 into the cavity 32 of the reaction chamber 30 .
  • the dispensing units 34 and 38 comprise a dual-lumen, plunger-activated dispensing tube 39 which extends within the pusher 16 from the proximal end portion 18 to the distal end portion 20 of the pusher 16 .
  • a distal end portion 41 of the dual lumen dispensing tube 39 may extend through the membrane 31 of the reaction chamber 30 into the cavity 32 .
  • the membrane 31 and dispensing tube 39 may be attached and sealed together by an adhesive, such as a silicone or cyanoacrylate adhesive.
  • an adhesive such as a silicone or cyanoacrylate adhesive.
  • the membrane 31 may be wrapped around the dispensing tube 39 and attached and sealed with a similar adhesive.
  • Other connection approaches can be practiced, such as those incorporating shrink tubing or other connector members.
  • the reactants 36 , 40 may be dispensed from the lumens to the cavity 30 by activating a plunger 42 (which can be seen in FIG. 1 ) located at a proximal end portion of the dispensing tube 39 .
  • a plunger 42 which can be seen in FIG. 1
  • the reactants prior to dispensing them, are secured within the respective lumens by a breakable seal 51 , 52 , respectively.
  • Such seals should be selected to be made of a material that does not significantly degrade while in contact with the reactant materials.
  • a fluid pressure release feature can be included to prevent the build up of fluid pressure within the reaction chamber when dispensing the reactants. This may take the form of a vent lumen 54 ( FIG. 2 ).
  • first and second reactants 36 , 40 are dispensed into the cavity 32 , they are mixed to produce a product 44 which has a greater volume than the combined volume of the first and second reactants prior to mixing.
  • the expanding product 44 pushes against the inner surface 33 of the membrane 31 , causing the membrane 31 to outwardly expand.
  • the force of the expanded membrane 31 against the gripping element 24 forces the gripping element to outwardly expand or open. Movement in this regard can be in a generally radial direction.
  • the expanding membrane 31 also may contact the headpiece 26 of the occlusion device 28 and push the headpiece 26 out of and away from the expanded gripping element 24 , when this action is desired.
  • the first and second reactants 36 , 40 can be any reactants that produce a product 44 having a greater volume than the original compositions.
  • the first and second reactants may be any of the reactants disclosed in Cooke et al. WO 92/09651, hereby incorporated herein by reference, which produce a polycyanoacrylate foam.
  • the first reactant is preferably a mixture of cyanoacrylate monomer and ethanol and the second reactant is preferably a mixture of ethanol and N,N-Dimethyl-p-toluidine.
  • Other reactant materials, that when combined form a foam material with an increased bulk volume relative to the reactants, such as precursors for polyurethane foam, are also suitable.
  • the catheter 12 is inserted into the vasculature system of a patient and positioned at a preselected location within a blood vessel 56 , typically in conjunction with other devices and professional procedures as generally known in the art.
  • the delivery unit 14 is inserted into the catheter 12 , and as shown in FIG. 5 , once the desired location is reached, the delivery unit 14 is advanced, and/or the catheter 12 is moved in a retrograde manner, such that the delivery unit moves with respect to and within the catheter until the occlusion device 28 moves through the catheter 12 and out of the distal end of the catheter.
  • the occlusion device may be retrieved back into the distal end of the catheter by retracting the delivery unit 14 proximally or advancing the catheter distally. Once the occlusion device has been retrieved, the catheter and/or the occlusion device may be repositioned.
  • the plunger 42 may be activated to dispense the first and second reactants 36 , 40 into the cavity 32 of the reaction chamber 30 .
  • the first and second reactants 36 , 40 mix within the cavity 32 and react to form a product 44 which has a larger volume than the combined volumes of the first and second reactants prior to mixing.
  • the expanding product 44 pushes against the inner wall 33 of the membrane 31 of the reaction chamber 30 , causing the membrane 31 to expand.
  • the expanded membrane 31 presses against the gripping element 24 outwardly expanding or opening the gripping element to release the occlusion device 28 at the preselected location within the blood vessel 56 .
  • the membrane 31 may simultaneously press against the headpiece 26 to push it out of and away from the gripping element 24 , thereby deploying the vascular occlusion device 28 .

Landscapes

  • Health & Medical Sciences (AREA)
  • Surgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Molecular Biology (AREA)
  • Vascular Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Reproductive Health (AREA)
  • Medical Informatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Surgical Instruments (AREA)
  • Materials For Medical Uses (AREA)
  • Media Introduction/Drainage Providing Device (AREA)
US11/171,896 2005-06-30 2005-06-30 Chemically based vascular occlusion device deployment with gripping feature Expired - Fee Related US7357809B2 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
US11/171,896 US7357809B2 (en) 2005-06-30 2005-06-30 Chemically based vascular occlusion device deployment with gripping feature
EP06253235A EP1738694B1 (fr) 2005-06-30 2006-06-22 Système de déploiement à base chimique avec élément de serrage pour un dispositif d'occlusion vasculaire
DE602006001993T DE602006001993D1 (de) 2005-06-30 2006-06-22 Chemisch basierte Einführvorrichtung mit einer Greifvorrichtung für eine vaskulare Okklusionsvorrichtung
JP2006180042A JP5259058B2 (ja) 2005-06-30 2006-06-29 把持部を有する脈管閉塞デバイスの化学ベースによる配置
CA2551328A CA2551328C (fr) 2005-06-30 2006-06-29 Dispositif de mise en place d'un dispositif d'occlusion vasculaire faisant appel a un procede chimique et dote d'un element de prehension

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US11/171,896 US7357809B2 (en) 2005-06-30 2005-06-30 Chemically based vascular occlusion device deployment with gripping feature

Publications (2)

Publication Number Publication Date
US20070005098A1 US20070005098A1 (en) 2007-01-04
US7357809B2 true US7357809B2 (en) 2008-04-15

Family

ID=37025140

Family Applications (1)

Application Number Title Priority Date Filing Date
US11/171,896 Expired - Fee Related US7357809B2 (en) 2005-06-30 2005-06-30 Chemically based vascular occlusion device deployment with gripping feature

Country Status (5)

Country Link
US (1) US7357809B2 (fr)
EP (1) EP1738694B1 (fr)
JP (1) JP5259058B2 (fr)
CA (1) CA2551328C (fr)
DE (1) DE602006001993D1 (fr)

Cited By (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060247572A1 (en) * 2005-04-28 2006-11-02 C. R. Bard, Inc. Medical device removal system
US20070005099A1 (en) * 2005-06-30 2007-01-04 Jones Donald K Chemically based vascular occlusion device deployment
US20070270930A1 (en) * 2006-05-18 2007-11-22 Schenck Jessica T Vascular occlusion device deployment system with gripping feature opened by a collapsible reaction chamber
US20080125855A1 (en) * 2002-07-19 2008-05-29 Hans Henkes Medical implant having a curlable matrix structure
US20080269774A1 (en) * 2006-10-26 2008-10-30 Chestnut Medical Technologies, Inc. Intracorporeal Grasping Device
US20090163986A1 (en) * 2007-12-21 2009-06-25 Microvention, Inc System And Method Of Detecting Implant Detachment
US20090163780A1 (en) * 2007-12-21 2009-06-25 Microvention, Inc. System And Method For Locating Detachment Zone Of A Detachable Implant
US20090275971A1 (en) * 2007-10-30 2009-11-05 Boston Scientific Scimed, Inc. Energy activated preloaded detachment mechanisms for implantable devices
US8679142B2 (en) 2008-02-22 2014-03-25 Covidien Lp Methods and apparatus for flow restoration
US9039749B2 (en) 2010-10-01 2015-05-26 Covidien Lp Methods and apparatuses for flow restoration and implanting members in the human body
US10076399B2 (en) 2013-09-13 2018-09-18 Covidien Lp Endovascular device engagement
US10413310B2 (en) 2007-10-17 2019-09-17 Covidien Lp Restoring blood flow and clot removal during acute ischemic stroke
US10722255B2 (en) 2008-12-23 2020-07-28 Covidien Lp Systems and methods for removing obstructive matter from body lumens and treating vascular defects
US11337714B2 (en) 2007-10-17 2022-05-24 Covidien Lp Restoring blood flow and clot removal during acute ischemic stroke

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008148049A1 (fr) * 2007-05-23 2008-12-04 Interventional & Surgical Innovations Llc Filtre de veine
DE102009056448B4 (de) * 2009-12-01 2011-11-10 Acandis Gmbh & Co. Kg Zufuhrsystem für ein medizinisches Funktionselement
GB2509952B (en) * 2013-01-18 2015-01-28 Cook Medical Technologies Llc Medical device loading and carrier tool
AU2014312175A1 (en) * 2013-08-30 2016-02-18 Arsenal Medical, Inc. Delivery catheters for in situ forming foams

Citations (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5002556A (en) 1986-11-29 1991-03-26 Terumo Kabushiki Kaisha Balloon catheter assembly
US5108407A (en) 1990-06-08 1992-04-28 Rush-Presbyterian St. Luke's Medical Center Method and apparatus for placement of an embolic coil
WO1992009651A1 (fr) 1990-11-30 1992-06-11 Chemence Limited Mousse polycyanacrylate
US5609608A (en) 1995-10-27 1997-03-11 Regents Of The University Of California Miniature plastic gripper and fabrication method
US5637087A (en) * 1995-03-22 1997-06-10 Abbott Laboratories Prefilled, two-constituent syringe
US5989242A (en) 1995-06-26 1999-11-23 Trimedyne, Inc. Therapeutic appliance releasing device
US6063100A (en) 1998-03-10 2000-05-16 Cordis Corporation Embolic coil deployment system with improved embolic coil
US6068644A (en) 1998-03-10 2000-05-30 Cordis Corporation Embolic coil hydraulic deployment system having improved catheter
US6238415B1 (en) 1994-12-22 2001-05-29 Target Therapeutics, Inc Implant delivery assembly with expandable coupling/decoupling mechanism
US6277125B1 (en) 1998-10-05 2001-08-21 Cordis Neurovascular, Inc. Embolic coil deployment system with retaining jaws
US6361547B1 (en) * 1998-03-10 2002-03-26 Cordis Corporation Embolic coil hydraulic deployment system
US6478773B1 (en) 1998-12-21 2002-11-12 Micrus Corporation Apparatus for deployment of micro-coil using a catheter
US6494884B2 (en) 2001-02-09 2002-12-17 Concentric Medical, Inc. Methods and devices for delivering occlusion elements
US6641576B1 (en) 1998-05-28 2003-11-04 Georgia Tech Research Corporation Devices for creating vascular grafts by vessel distension using rotatable elements
US20030220666A1 (en) 2002-05-24 2003-11-27 Scimed Life Systems, Inc. Solid embolic material with variable expansion
US6689141B2 (en) 2000-10-18 2004-02-10 Microvention, Inc. Mechanism for the deployment of endovascular implants
US6743236B2 (en) 1998-10-05 2004-06-01 Cordis Corporation Heated vascular occlusion coil deployment system
US20040153025A1 (en) 2003-02-03 2004-08-05 Seifert Paul S. Systems and methods of de-endothelialization
US20040218966A1 (en) 2003-04-29 2004-11-04 Fuller Douglas D. Hand-held self-dispensing applicator
US20040225279A1 (en) 2001-06-01 2004-11-11 Jean Raymond Detachable tip microcatheter for use of liquid embolic agents
US6871594B1 (en) 2003-04-01 2005-03-29 Randall P. Estrella Reusable paint grenade

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07116262A (ja) * 1993-10-22 1995-05-09 Olympus Optical Co Ltd 医療用膨張体

Patent Citations (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5002556A (en) 1986-11-29 1991-03-26 Terumo Kabushiki Kaisha Balloon catheter assembly
US5108407A (en) 1990-06-08 1992-04-28 Rush-Presbyterian St. Luke's Medical Center Method and apparatus for placement of an embolic coil
WO1992009651A1 (fr) 1990-11-30 1992-06-11 Chemence Limited Mousse polycyanacrylate
US6238415B1 (en) 1994-12-22 2001-05-29 Target Therapeutics, Inc Implant delivery assembly with expandable coupling/decoupling mechanism
EP1537838A1 (fr) 1994-12-22 2005-06-08 Boston Scientific Limited Ensemble pour positioner un implant, avec mécanisme de couplage ou découplage extensible
US5637087A (en) * 1995-03-22 1997-06-10 Abbott Laboratories Prefilled, two-constituent syringe
US5989242A (en) 1995-06-26 1999-11-23 Trimedyne, Inc. Therapeutic appliance releasing device
US5609608A (en) 1995-10-27 1997-03-11 Regents Of The University Of California Miniature plastic gripper and fabrication method
US6361547B1 (en) * 1998-03-10 2002-03-26 Cordis Corporation Embolic coil hydraulic deployment system
US6068644A (en) 1998-03-10 2000-05-30 Cordis Corporation Embolic coil hydraulic deployment system having improved catheter
US6063100A (en) 1998-03-10 2000-05-16 Cordis Corporation Embolic coil deployment system with improved embolic coil
US6641576B1 (en) 1998-05-28 2003-11-04 Georgia Tech Research Corporation Devices for creating vascular grafts by vessel distension using rotatable elements
US6743236B2 (en) 1998-10-05 2004-06-01 Cordis Corporation Heated vascular occlusion coil deployment system
US6277125B1 (en) 1998-10-05 2001-08-21 Cordis Neurovascular, Inc. Embolic coil deployment system with retaining jaws
US6478773B1 (en) 1998-12-21 2002-11-12 Micrus Corporation Apparatus for deployment of micro-coil using a catheter
US6689141B2 (en) 2000-10-18 2004-02-10 Microvention, Inc. Mechanism for the deployment of endovascular implants
US6494884B2 (en) 2001-02-09 2002-12-17 Concentric Medical, Inc. Methods and devices for delivering occlusion elements
US20040225279A1 (en) 2001-06-01 2004-11-11 Jean Raymond Detachable tip microcatheter for use of liquid embolic agents
US20030220666A1 (en) 2002-05-24 2003-11-27 Scimed Life Systems, Inc. Solid embolic material with variable expansion
US20040153025A1 (en) 2003-02-03 2004-08-05 Seifert Paul S. Systems and methods of de-endothelialization
US6871594B1 (en) 2003-04-01 2005-03-29 Randall P. Estrella Reusable paint grenade
US20040218966A1 (en) 2003-04-29 2004-11-04 Fuller Douglas D. Hand-held self-dispensing applicator

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
European Search Report in EP 06 25 3235, dated Oct. 24, 2006.

Cited By (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11426293B2 (en) 2002-07-19 2022-08-30 Ussc Medical Gmbh Medical implant
US10342683B2 (en) 2002-07-19 2019-07-09 Ussc Medical Gmbh Medical implant having a curlable matrix structure and method of use
US20080125855A1 (en) * 2002-07-19 2008-05-29 Hans Henkes Medical implant having a curlable matrix structure
US8632584B2 (en) 2002-07-19 2014-01-21 Dendron Gmbh Medical implant having a curlable matrix structure and method of use
US20060247572A1 (en) * 2005-04-28 2006-11-02 C. R. Bard, Inc. Medical device removal system
US8025668B2 (en) * 2005-04-28 2011-09-27 C. R. Bard, Inc. Medical device removal system
US7780695B2 (en) * 2005-06-30 2010-08-24 Codman & Shurtleff, Inc. Chemically based vascular occlusion device deployment
US8206413B2 (en) 2005-06-30 2012-06-26 Codman & Shurtleff, Inc. Chemically based vascular occlusion device deployment
US20070005099A1 (en) * 2005-06-30 2007-01-04 Jones Donald K Chemically based vascular occlusion device deployment
US20100286723A1 (en) * 2005-06-30 2010-11-11 Codman & Shurtleff, Inc. Chemically based vascular occlusion device deployment
US20070270930A1 (en) * 2006-05-18 2007-11-22 Schenck Jessica T Vascular occlusion device deployment system with gripping feature opened by a collapsible reaction chamber
US8721701B2 (en) * 2006-05-18 2014-05-13 DePuy Synthes Products, LLC Vascular occlusion device deployment system with gripping feature opened by a collapsible reaction chamber
US20080269774A1 (en) * 2006-10-26 2008-10-30 Chestnut Medical Technologies, Inc. Intracorporeal Grasping Device
US20100331853A1 (en) * 2006-10-26 2010-12-30 Chestnut Medical Technologies, Inc. Intracorporeal grasping device
US8298244B2 (en) 2006-10-26 2012-10-30 Tyco Healtcare Group Lp Intracorporeal grasping device
US10413310B2 (en) 2007-10-17 2019-09-17 Covidien Lp Restoring blood flow and clot removal during acute ischemic stroke
US11337714B2 (en) 2007-10-17 2022-05-24 Covidien Lp Restoring blood flow and clot removal during acute ischemic stroke
US20090275971A1 (en) * 2007-10-30 2009-11-05 Boston Scientific Scimed, Inc. Energy activated preloaded detachment mechanisms for implantable devices
US10299755B2 (en) 2007-12-21 2019-05-28 Microvention, Inc. System and method for locating detachment zone of a detachable implant
US20090163780A1 (en) * 2007-12-21 2009-06-25 Microvention, Inc. System And Method For Locating Detachment Zone Of A Detachable Implant
US8192480B2 (en) 2007-12-21 2012-06-05 Microvention, Inc. System and method of detecting implant detachment
US8460332B2 (en) 2007-12-21 2013-06-11 Microvention, Inc. System and method of detecting implant detachment
US20090163986A1 (en) * 2007-12-21 2009-06-25 Microvention, Inc System And Method Of Detecting Implant Detachment
US9242070B2 (en) 2007-12-21 2016-01-26 MicronVention, Inc. System and method for locating detachment zone of a detachable implant
US10456151B2 (en) 2008-02-22 2019-10-29 Covidien Lp Methods and apparatus for flow restoration
US9161766B2 (en) 2008-02-22 2015-10-20 Covidien Lp Methods and apparatus for flow restoration
US8940003B2 (en) 2008-02-22 2015-01-27 Covidien Lp Methods and apparatus for flow restoration
US8679142B2 (en) 2008-02-22 2014-03-25 Covidien Lp Methods and apparatus for flow restoration
US11529156B2 (en) 2008-02-22 2022-12-20 Covidien Lp Methods and apparatus for flow restoration
US10722255B2 (en) 2008-12-23 2020-07-28 Covidien Lp Systems and methods for removing obstructive matter from body lumens and treating vascular defects
US10426644B2 (en) 2010-10-01 2019-10-01 Covidien Lp Methods and apparatuses for flow restoration and implanting members in the human body
US9039749B2 (en) 2010-10-01 2015-05-26 Covidien Lp Methods and apparatuses for flow restoration and implanting members in the human body
US10076399B2 (en) 2013-09-13 2018-09-18 Covidien Lp Endovascular device engagement
US11304712B2 (en) 2013-09-13 2022-04-19 Covidien Lp Endovascular device engagement

Also Published As

Publication number Publication date
EP1738694A1 (fr) 2007-01-03
CA2551328C (fr) 2014-10-07
JP2007014763A (ja) 2007-01-25
JP5259058B2 (ja) 2013-08-07
DE602006001993D1 (de) 2008-09-11
EP1738694B1 (fr) 2008-07-30
US20070005098A1 (en) 2007-01-04
CA2551328A1 (fr) 2006-12-30

Similar Documents

Publication Publication Date Title
US7357809B2 (en) Chemically based vascular occlusion device deployment with gripping feature
US8449591B2 (en) Chemically based vascular occlusion device deployment
US8721701B2 (en) Vascular occlusion device deployment system with gripping feature opened by a collapsible reaction chamber
US8206413B2 (en) Chemically based vascular occlusion device deployment
US7708755B2 (en) Stretch resistant embolic coil delivery system with combined mechanical and pressure release mechanism
US6102932A (en) Intravascular device push wire delivery system
CA2411164C (fr) Gaine rechargeable pour systeme de catheter pour la mise en place de dispositifs vasoocclusifs
EP2001543B1 (fr) Enroulement détachable thermique
US20080269719A1 (en) Implantable medical device delivery system with a frangible portion and methods of making and using the same
US20050149108A1 (en) Implant delivery and detachment system and method
EP1738693B1 (fr) Système de détachement par laser d'un dispositif d'occlusion vasculaire
JP2007160086A (ja) 塞栓器具の送達システム
US20060241682A1 (en) Intravascular device push wire delivery system
EP1307145B1 (fr) Systeme d'administration intravasculaire
US7819889B2 (en) Detachable introducer for a medical device deployment system
US8920457B2 (en) Modified headpiece for hydraulic coil deployment system
US7670353B2 (en) Modified headpiece for hydraulic coil deployment system

Legal Events

Date Code Title Description
AS Assignment

Owner name: CORDIS DEVELOPMENT CORPORATION, FLORIDA

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:JONES, DONALD K.;MITELBERG, VLADIMIR;REEL/FRAME:016687/0041

Effective date: 20051012

AS Assignment

Owner name: CORDIS NEUROVASCULAR, INC., FLORIDA

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:CORDIS DEVELOPMENT CORPORATION;REEL/FRAME:017961/0930

Effective date: 20051012

AS Assignment

Owner name: CODMAN & SHURTLEFF, INC., MASSACHUSETTS

Free format text: MERGER;ASSIGNOR:CORDIS NEUROVASCULAR, INC.;REEL/FRAME:023032/0233

Effective date: 20081216

Owner name: CODMAN & SHURTLEFF, INC.,MASSACHUSETTS

Free format text: MERGER;ASSIGNOR:CORDIS NEUROVASCULAR, INC.;REEL/FRAME:023032/0233

Effective date: 20081216

FPAY Fee payment

Year of fee payment: 4

REMI Maintenance fee reminder mailed
LAPS Lapse for failure to pay maintenance fees
STCH Information on status: patent discontinuation

Free format text: PATENT EXPIRED DUE TO NONPAYMENT OF MAINTENANCE FEES UNDER 37 CFR 1.362

FP Expired due to failure to pay maintenance fee

Effective date: 20160415